Clearmind Medicine (CMND) Short Interest Ratio & Short Volume $1.02 +0.01 (+0.99%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Clearmind Medicine Short Interest DataClearmind Medicine (CMND) has a short interest of 117,800 shares, representing 3.95% of the float (the number of shares available for trading by the public). This marks a -36.12% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 1.09 million shares to cover all short positions.Current Short Interest117,800 sharesPrevious Short Interest184,400 sharesChange Vs. Previous Month-36.12%Dollar Volume Sold Short$108,376.00Short Interest Ratio0.5 Days to CoverLast Record DateApril 15, 2025Outstanding Shares4,265,000 sharesFloat Size2,980,000 sharesShort Percent of Float3.95%Today's Trading Volume29,186 sharesAverage Trading Volume1,086,409 sharesToday's Volume Vs. Average3% Short Selling Clearmind Medicine? Sign up to receive the latest short interest report for Clearmind Medicine and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCMND Short Interest Over TimeCMND Days to Cover Over TimeCMND Percentage of Float Shorted Over Time Clearmind Medicine Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2025117,800 shares $108,376.00 -36.1%4.0%0.5 $0.92 3/31/2025184,400 shares $190,854.00 -5.2%6.2%2.1 $1.04 3/15/2025194,500 shares $221,730.00 -23.9%6.5%0.2 $1.14 2/28/2025255,600 shares $309,276.00 -6.9%8.6%0.3 $1.21 2/15/2025274,600 shares $387,186.00 -16.0%9.2%0.3 $1.41 1/31/2025326,800 shares $450,984.00 -20.4%11.0%0.3 $1.38 1/15/2025410,400 shares $627,912.00 -33.9%13.8%0.4 $1.53 12/31/2024620,700 shares $856,566.00 +453.7%21.0%0.5 $1.38 12/15/2024112,100 shares $165,156.93 -41.6%3.8%0.1 $1.47 11/30/2024192,100 shares $249,730.00 +2.4%6.4%0.8 $1.30 Get the Latest News and Ratings for CMND and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Clearmind Medicine and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024187,600 shares $251,384.00 -40.8%6.2%0.7 $1.34 10/31/2024316,600 shares $440,074.00 +45.6%10.5%0.8 $1.39 10/15/2024217,400 shares $345,666.00 +7.9%7.2%0.6 $1.59 9/30/2024201,400 shares $245,708.00 -13.2%6.8%0.5 $1.22 9/15/2024231,900 shares $310,746.00 -5.7%7.8%0.1 $1.34 8/31/2024245,800 shares $321,998.00 +10.2%8.3%0.1 $1.31 8/15/2024223,100 shares $254,334.00 -49.2%7.6%0.1 $1.14 7/31/2024439,100 shares $728,906.00 -2.7%15.0%0.2 $1.66 7/15/2024451,400 shares $1.00 million +32.0%15.5%0.2 $2.22 6/30/2024342,000 shares $574,560.00 +0.2%11.7%0.1 $1.68 6/15/2024341,200 shares $378,732.00 +151.8%11.7%0.3 $1.11 5/31/2024135,500 shares $151,760.00 -44.1%4.6%0.1 $1.12 5/15/2024242,200 shares $310,016.00 +50.5%8.3%0.2 $1.28 4/30/2024160,900 shares $191,100.93 +0.4%5.5%0.1 $1.19 4/15/2024160,200 shares $201,852.00 -10.4%5.5%0.2 $1.26 3/31/2024178,800 shares $205,620.00 +92.9%6.1%0.1 $1.15 3/15/202492,700 shares $117,729.00 -59.8%3.2%0.1 $1.27 2/29/2024230,700 shares $355,278.00 +31.3%7.9%0.1 $1.54 2/15/2024175,700 shares $237,195.00 +20.0%6.0%0.1 $1.35 1/31/2024146,400 shares $209,352.00 -83.0%5.4%0.1 $1.43 1/15/2024862,800 shares $1.17 million +5,891.7%52.6%0.4 $1.36 12/31/202314,400 shares $40,464.00 -65.4%0.9%0 $2.81 12/15/202341,600 shares $116,064.00 -70.6%2.7%0 $2.79 11/30/2023141,400 shares $494,900.00 +50.4%26.4%0.1 $3.50 11/15/202394,000 shares $358,140.00 -70.8%0.7%0 $3.81 10/31/2023322,000 shares $39,251.80 -90.1%2.5%0.2 $0.12 10/15/20233,240,000 shares $579,960.00 +2,129.9%24.3%1.8 $0.18 9/30/2023145,300 shares $23,248.00 -69.0%1.1%0.3 $0.16 9/15/2023468,400 shares $84,077.80 +141.3%9.4%1.3 $0.18 8/31/2023194,100 shares $75,931.92 +106.3%3.9%0.8 $0.39Donald Trump is about to free crypto from its chains … (Ad)Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election … surpassing $100,000 on Dec. 8 .… Now Juan believes it could hit $150,000 … or higher in 2025.There's another coin he thinks could do even better. 8/15/202394,100 shares $40,839.40 -6.2%1.9%0.4 $0.43 7/31/2023100,300 shares $44,132.00 +6.9%2.0%0.2 $0.44 7/15/202393,800 shares $41,975.50 -7.5%1.9%0.1 $0.45 6/30/2023101,400 shares $48,165.00 -31.3%2.0%0.1 $0.48 6/15/2023147,500 shares $80,387.50 -37.0%2.9%0.1 $0.55 5/31/2023234,000 shares $135,720.00 -4.4%4.6%0.1 $0.58 5/15/2023244,700 shares $148,532.90 No Change4.8%0.1 $0.61 CMND Short Interest - Frequently Asked Questions What is Clearmind Medicine's current short interest? Short interest is the volume of Clearmind Medicine shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 117,800 shares of CMND short. 3.95% of Clearmind Medicine's shares are currently sold short. Learn More on Clearmind Medicine's current short interest. What is a good short interest percentage for Clearmind Medicine? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.95% of Clearmind Medicine's floating shares are currently sold short. Is Clearmind Medicine's short interest increasing or decreasing? Clearmind Medicine saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 117,800 shares, a decrease of 36.1% from the previous total of 184,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Clearmind Medicine's float size? Clearmind Medicine currently has issued a total of 4,265,000 shares. Some of Clearmind Medicine's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Clearmind Medicine currently has a public float of 2,980,000 shares. How does Clearmind Medicine's short interest compare to its competitors? 3.95% of Clearmind Medicine's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Clearmind Medicine: Allarity Therapeutics, Inc. (11.15%), Chemomab Therapeutics Ltd. (0.81%), Sol-Gel Technologies Ltd. (0.50%), Equillium, Inc. (1.10%), Unity Biotechnology, Inc. (4.83%), Cingulate Inc. (4.50%), Edesa Biotech, Inc. (0.90%), Natural Alternatives International, Inc. (0.09%), Lipocine Inc. (1.39%), Leap Therapeutics, Inc. (11.30%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Clearmind Medicine stock? Short selling CMND is an investing strategy that aims to generate trading profit from Clearmind Medicine as its price is falling. CMND shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Clearmind Medicine? A short squeeze for Clearmind Medicine occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CMND, which in turn drives the price of the stock up even further. How often is Clearmind Medicine's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CMND, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies Allarity Therapeutics Short Interest Data Chemomab Therapeutics Short Interest Data Sol-Gel Technologies Short Interest Data Equillium Short Interest Data Unity Biotechnology Short Interest Data Cingulate Short Interest Data Edesa Biotech Short Interest Data Natural Alternatives International Short Interest Data Lipocine Short Interest Data Leap Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CMND) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearmind Medicine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clearmind Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.